2026 Optometrist Report
Download the free report to understand how optometrists today are advancing their careers, managing their practices, and adapting to evolving trends in eyecare.
New Content
24-Month ELIOS Data: IOP, Medication, and Safety Outcomes
Sit down with Drs. Mark Gallardo and Steven Sarkisian to review 24-month findings from the pivotal trial for ELIOS combined with cataract surgery.
Systems That Keep Patients Buying Lenses In-House
Consider approaches optometrists can take to increase the number of patients who purchase contact lenses at the office instead of online retailers.
A Concise Workflow for Identifying and Monitoring Glaucoma Suspects
Review step by step pearls for diagnosing and managing glaucoma suspects, and how a shift toward earlier procedural intervention is reducing drop burden.
Topics
Remigromig in DME: What BRUNELLO Shows and What BAROLO Must Answer
Barriers to Oculomics and How to Overcome Them
2026 Contact Lens Report
Download the free report to learn how optometrists are managing their contact lens practices in 2026!
Johnson & Johnson to acquire Ollin Biosciences in deal worth up to $3.3B
Pending transaction includes phase 3 funding for OLN324, an investigational bispecific antibody under evaluation for wet AMD and DME.
i-Lumen reports new i-SIGHT data on retinal bioelectric stimulation for dry AMD
Expanded clinical findings from U.S.-based feasibility trial include a ≥10-ETDRS letter improvement among over 50% of treated patients.
IMVIONIX debuts with acquisition of BEOVU's North American rights
Biotech company launches to commercial space; secures U.S. and Canadian exclusive rights to the FDA-approved injection for wet AMD and DME.
The Ultimate Guide to Interventional Glaucoma with the Glaukos Portfolio
Interventional glaucoma is a treatment approach for managing ocular hypertension and various stages of glaucoma. Join Drs. Shah, Ristvedt, Micheletti, Funke, and Yadgarov as they discuss the available treatment options and how this new approach is influencing glaucoma management.
The Role of Tear Film Biomarkers in Diagnosing and Managing DED
Sit down with Drs. Damon Dierker and Jerry Robben to review how to interpret and integrate tear film biomarkers into dry eye disease management workflows.
Geographic Atrophy: Why Early Detection is the New Standard of Care
How clinical data from the past three years have shifted the treatment landscape and reformed the clinical calculus when it comes to managing geographic atrophy patients.
Clinical Specialties
24-Month ELIOS Data: IOP, Medication, and Safety Outcomes
A Concise Workflow for Identifying and Monitoring Glaucoma Suspects
Remigromig in DME: What BRUNELLO Shows and What BAROLO Must Answer
Systems That Keep Patients Buying Lenses In-House
Consider approaches optometrists can take to increase the number of patients who purchase contact lenses at the office instead of online retailers.
2026 Optometrist Report
Download the free report to understand how optometrists today are advancing their careers, managing their practices, and adapting to evolving trends in eyecare.
How DTC Advertising is Driving Presbyopia Drop Conversations in Practice
Joins Drs. Coats, Davison, Ramsey and Schaeffer to review how direct-to-consumer (DTC) advertising impacts patient conversations about presbyopia drops.
Careers
How I Made CareCredit Simple for My Team and Patients
The Impact of Presbyopia Drops on Optical Sales
Benchmarking Your Contact Lens KPIs: What Top-Performing Practices Are Tracking
Featured Writers
Become a WriterThe Ultimate Guide to Interventional Glaucoma with the Glaukos Portfolio
Interventional glaucoma is a treatment approach for managing ocular hypertension and various stages of glaucoma. Join Drs. Shah, Ristvedt, Micheletti, Funke, and Yadgarov as they discuss the available treatment options and how this new approach is influencing glaucoma management.
